1. Academic Validation
  2. Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates

Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates

  • Immune Netw. 2022 Apr 15;22(3):e28. doi: 10.4110/in.2022.22.e28.
Sumin Kim 1 2 3 Seo Hyeong Park 1 2 3 Won Hoon Choi 1 3 Min Jae Lee 1 2
Affiliations

Affiliations

  • 1 Department of Biochemistry & Molecular Biology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • 2 Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
  • 3 BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul 03080, Korea.
Abstract

The 26S Proteasome irreversibly hydrolyzes polyubiquitylated substrates to maintain protein homeostasis; it also regulates immune responses by generating antigenic Peptides. An alternative form of the 26S Proteasome is the immunoproteasome, which contains substituted catalytic subunits (β1i/PSMB9, β2i/PSMB10, and β5i/PSMB8) instead of constitutively expressed counterparts (β1/PSMB6, β2/PSMB7, and β5/PSMB5). The immunoproteasome expands the peptide repertoire presented on MHC class I molecules. However, how its activity changes in this context is largely elusive, possibly due to the lack of a standardized methodology to evaluate its specific activity. Here, we describe an assay protocol that measures the immunoproteasome activity of whole-cell lysates using commercially available fluorogenic peptide substrates. Our results showed that the most accurate assessment of immunoproteasome activity could be achieved by combining β5i-targeting substrate Ac-ANW-AMC and immunoproteasome inhibitor ONX-0914. This simple and reliable protocol may contribute to future studies of immunoproteasomes and their pathophysiological roles during viral Infection, inflammation, and tumorigenesis.

Keywords

Fluorogenic substrates; Immunoproteasome; Proteasome; Proteasome inhibitors.

Figures
Products